EcoDrugPlus

Glucagon Receptor

Ensembl ID : ENSMAUG00000015684
Gene Symbol: GCGR
3 Cross references
183 Possible Orthologues:

Glucagon-Like Peptide 1 Receptor

Ensembl ID : ENSMAUG00000014036
Gene Symbol: GLP1R
1 Cross references
133 Possible Orthologues:

Glucokinase

Ensembl ID : ENSMAUG00000003438
Gene Symbol: GCK
3 Cross references
211 Possible Orthologues:

Glucosidase Alpha, Acid

Ensembl ID : ENSMAUG00000020264
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Glucosylceramidase Beta

Ensembl ID : ENSMAUG00000004476
Gene Symbol: GBA
4 Cross references
254 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 1

Ensembl ID : ENSMAUG00000022238
Gene Symbol: GRIA1
4 Cross references
323 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSMAUG00000015836
Gene Symbol: GRIA2
3 Cross references
321 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 3

Ensembl ID : ENSMAUG00000009295
Gene Symbol: GRIA3
4 Cross references
318 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 4

Ensembl ID : ENSMAUG00000016775
Gene Symbol: GRIA4
3 Cross references
324 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 1

Ensembl ID : ENSMAUG00000019825
Gene Symbol: GRIN1
4 Cross references
278 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2a

Ensembl ID : ENSMAUG00000009472
Gene Symbol: GRIN2A
4 Cross references
227 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2b

Ensembl ID : ENSMAUG00000010364
Gene Symbol: GRIN2B
4 Cross references
330 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).